Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Complex Drugs

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Complex Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Complex Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Complex Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
NUTRICIA32
STRAWMAN24
SOCIETE DES PRODUITS NESTLE21
FRESENIUS KABI DEUTSCHLAND15
HOFFMANN EITLE9
MARGARET DIXON8
ARLA FOODS AMBA8
FRIESLANDCAMPINA NEDERLAND7
ABBOTT LABORATORIES5
CHR HANSEN5

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
SOCIT DES PRODUITS NESTL40
NESTEC38
NUTRICIA36
THE UNIVERSITY OF TOKYO11
THE A MILK8
GENZYME7
BLUEBIRD BIO7
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA7
BHLER INSECT TECHNOLOGY SOLUTIONS6
BHLER6

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
NEDERLANDSCH OCTROOIBUREAU26
FRESENIUS KABI DEUTSCHLAND15
MEWBURN ELLIS14
ELKINGTON AND FIFE12
HOFFMANN EITLE10
BOULT WADE TENNANT8
CARPMAELS & RANSFORD8
D YOUNG7
FRIESLANDCAMPINA DEPARTMENT7
PLOUGMANN VINGTOFT7

Latest patents opposed in the Complex Drugs industry

Patent challenges are becoming increasingly common in the Complex Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Complex Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Complex Drugs industry

EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 24, 2025STRAWMAN
EP3411476Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 23, 2025MAIWALD
EP4216980C-Phycocyanin For Use In The Treatment And/Or Prevention Of Peripheral NeuropathyANILUR PHARMAJan 9, 2025ALGOSOURCE
EP3888674Treatment Of Cancer Using Anti-Cd19 Chimeric Antigen ReceptorTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 3, 2025J A KEMP
EP3493686Nutritional Compositions And Infant Formulas Comprising A Mix Of Oligosaccharides And Optionally Bifidobacterium Lactis For Preventing, Treating Or Reducing The Severity Of Non-Rotavirus-Associated DiarrhoeaNESTECJan 2, 2025FRIESLANDCAMPINA NEDERLAND
EP3226887Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3493686Nutritional Compositions And Infant Formulas Comprising A Mix Of Oligosaccharides And Optionally Bifidobacterium Lactis For Preventing, Treating Or Reducing The Severity Of Non-Rotavirus-Associated DiarrhoeaSOCIT DES PRODUITS NESTLDec 19, 2024NUTRICIA
EP3506915Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic DisordersPLAS FREEDec 5, 2024BIOTEST
EP3506915Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic DisordersPLAS FREEDec 4, 2024MARCHANT

Top patents facing oppositions in Complex Drugs industry

To stay ahead in the competitive Complex Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Complex Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2371361Aug 7, 2019Methods To Mobilize Progenitor/Stem CellsGENZYME7
EP2359701Jan 6, 2021Composition For Improving Membrane Composition And Functioning Of CellsNUTRICIA4
EP3539548Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory CellsTHE UNIVERSITY OF TOKYO4
EP2818055Oct 28, 2020High Energy Liquid Enteral Nutritional CompositionNUTRICIA4
EP3178483Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO4
EP3389630Nov 8, 2023Neoantigen Identification, Manufacture, And UseGRITSTONE BIO4
EP3177150Dec 23, 2020A Combination Of Vitamin D And Zinc And Its UseNESTEC3
EP2863762Aug 8, 2018Method To Convert Insects Or Worms Into Nutrient Streams And Compositions Obtained TherebyPROTIX BIOSYSTEMS3
EP2216028Dec 6, 2017Immunostimulation By Chemically Modified RnaCUREVAC3
EP2687106May 2, 2018High Energy Liquid Enteral Nutritional CompositionNUTRICIA3